Oshi Health used IBS Awareness Month to intensify education around gastrointestinal symptoms, urging patients to track stool patterns and bathroom habits using tools like the Bristol Stool Chart. The company positioned this education-first approach as a way to lower barriers to diagnosis, deepen patient engagement, and expand the top of its virtual GI care funnel.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
In parallel, Oshi highlighted a substantial access gap in gastroenterology, noting that two-thirds of U.S. counties lack a gastroenterologist even as 15% of covered lives seek GI care annually. Management is promoting a clinician-led virtual model capable of diagnosis, prescribing, and ongoing treatment, aimed at capturing higher-acuity, reimbursable services across underserved regions.
The company’s 2025 Impact Report featured multi-year outcomes indicating 97% of patients achieve symptom control, a 90% reduction in moderate-to-severe symptoms, and 97% patient satisfaction. Oshi also reported 68% fewer GI-related ER visits and 95% colorectal cancer screening compliance versus a 59% national rate, metrics designed to appeal to payers and employers focused on value-based care.
Economically, Oshi cited $6,081 in annual savings per member and an 8.17 return on investment based on matched claims analysis, reinforcing its pitch as a cost-containment solution in digestive health. These figures, while not yet independently detailed, form the backbone of its conversations with health plans, self-insured employers, and benefits consultants.
CEO Sam Holliday is set to present these outcomes at the Business Group on Health 2026 Annual Conference alongside leaders from Sedgwick, Progyny, Inc., and Microsoft, in a session centered on vendor accountability and impact measurement. Increased visibility at this employer-focused forum may help Oshi convert reported clinical and economic gains into broader commercial adoption and more predictable revenue.
Overall, the week underscored Oshi Health’s dual focus on patient education and data-backed performance, as it seeks to differentiate its clinician-led virtual GI platform and deepen traction with employers and payers in a structurally underserved market.